IL-15-based molecules and methods of use thereof
US11471511B2 · kind B2 · utility
11Cited by
24References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 9, 2020 |
| Grant date | Oct 18, 2022 |
| Priority date | — |
| Expiry date | Jul 12, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/32
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention features combination therapies using an IL-15-based superagonist complex and an antibody to effectively treat subjects with cancer and infectious diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.